Carbonatix Pre-Player Loader

Audio By Carbonatix

Lead vaccine candidates developed by Oxford ​University and ​Moderna against Ebola Bundibugyo, ⁠the deadly ​virus that has ​swept through eastern Democratic Republic of Congo, ​could enter ​Phase 1 trials as early ‌as ⁠July.

They say that field trials possible within several ​months, ​the ⁠head of the Coalition for ​Epidemic Preparedness ​Innovations, ⁠Richard Hatchett, said on Tuesday.

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:  
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.